144 related articles for article (PubMed ID: 25314009)
21. Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Feb; 8(8):14029-14038. PubMed ID: 28152511
[TBL] [Abstract][Full Text] [Related]
22. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
[TBL] [Abstract][Full Text] [Related]
24. Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.
Tang JM; Ma XM; Hou YL; Dai LY; Cao HB; Ye M; Bai YR
J Radiat Res; 2014 Jul; 55(4):794-802. PubMed ID: 24614820
[TBL] [Abstract][Full Text] [Related]
25. Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.
Xiong J; Krishnaswamy G; Raynor S; Loh KS; Kwa AL; Lim CM
Head Neck; 2016 Apr; 38 Suppl 1():E1660-5. PubMed ID: 26891064
[TBL] [Abstract][Full Text] [Related]
26. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
[TBL] [Abstract][Full Text] [Related]
27. The role of chemotherapy in the treatment of stage II nasopharyngeal carcinoma: Retrospective analysis of the national cancer database.
Ahmed Z; Kujtan L; Kennedy K; Wood V; Schomas D; Subramanian J
Cancer Med; 2019 Apr; 8(4):1500-1507. PubMed ID: 30790468
[TBL] [Abstract][Full Text] [Related]
28. Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study.
Chen TM; Lin KC; Yuan KS; Chang CL; Chow JM; Wu SY
Radiother Oncol; 2018 Oct; 129(1):23-29. PubMed ID: 29277447
[TBL] [Abstract][Full Text] [Related]
29. Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia.
Wildeman MA; Fles R; Herdini C; Indrasari RS; Vincent AD; Tjokronagoro M; Stoker S; Kurnianda J; Karakullukcu B; Taroeno-Hariadi KW; Hamming-Vrieze O; Middeldorp JM; Hariwiyanto B; Haryana SM; Tan IB
PLoS One; 2013; 8(5):e63706. PubMed ID: 23675501
[TBL] [Abstract][Full Text] [Related]
30. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study.
Fan CY; Lin CS; Chao HL; Huang WY; Su YF; Lin KT; Tsai IJ; Kao CH
Radiother Oncol; 2017 Jun; 123(3):394-400. PubMed ID: 28532605
[TBL] [Abstract][Full Text] [Related]
31. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
Chen L; Hu CS; Chen XZ; Hu GQ; Cheng ZB; Sun Y; Li WX; Chen YY; Xie FY; Liang SB; Chen Y; Xu TT; Li B; Long GX; Wang SY; Zheng BM; Guo Y; Sun Y; Mao YP; Tang LL; Chen YM; Liu MZ; Ma J
Lancet Oncol; 2012 Feb; 13(2):163-71. PubMed ID: 22154591
[TBL] [Abstract][Full Text] [Related]
32. A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma.
Wang J; Zheng J; Tang T; Zhu F; Yao Y; Xu J; Wang AZ; Zhang L
PLoS One; 2015; 10(4):e0124018. PubMed ID: 25915944
[TBL] [Abstract][Full Text] [Related]
33. NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma.
Lee AWM; Ngan RKC; Ng WT; Tung SY; Cheng AAC; Kwong DLW; Lu TX; Chan ATC; Sze HCK; Yiu HHY; Wong FCS; Yuen KT; Chappell R; Choi HCW
Cancer; 2020 Aug; 126(16):3674-3688. PubMed ID: 32497261
[TBL] [Abstract][Full Text] [Related]
34. Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre.
Colaco RJ; Betts G; Donne A; Swindell R; Yap BK; Sykes AJ; Slevin NJ; Homer JJ; Lee LW
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):171-7. PubMed ID: 23337060
[TBL] [Abstract][Full Text] [Related]
35. Post-treatment late complications of nasopharyngeal carcinoma.
Lee CC; Ho CY
Eur Arch Otorhinolaryngol; 2012 Nov; 269(11):2401-9. PubMed ID: 22249834
[TBL] [Abstract][Full Text] [Related]
36. Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.
Sun X; Zeng L; Chen C; Huang Y; Han F; Xiao W; Liu S; Lu T
Radiat Oncol; 2013 Nov; 8():265. PubMed ID: 24219818
[TBL] [Abstract][Full Text] [Related]
37. Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand.
Ngamphaiboon N; Dechaphunkul A; Setakornnukul J; Dechaphunkul T; Jiratrachu R; Suktitipat B; Jiarpinitnun C; Pattaranutaporn P; Danchaivijitr P
BMC Cancer; 2020 Jun; 20(1):518. PubMed ID: 32493288
[TBL] [Abstract][Full Text] [Related]
38. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.
Kwong DL; Sham JS; Chua DT; Choy DT; Au GK; Wu PM
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):703-10. PubMed ID: 9336153
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer.
Lin JC; Jan JS; Hsu CY
Am J Clin Oncol; 1997 Feb; 20(1):6-10. PubMed ID: 9020279
[TBL] [Abstract][Full Text] [Related]
40. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
